A woman has joined thousands more across the country who believe she was injured by defective transvaginal mesh surgical devices manufactured by Ethicon Inc. and Johnson & Johnson.
The woman has filed a lawsuit that’s been added to a growing number of other complaints that say these companies failed to warn about the dangers of their Gynecare Prolift + M™ and the TVT Secur™ transvaginal mesh devices and that led to a series of painful complications and revision surgeries. This lawsuit has been added to the Re: Ethicon Inc., Pelvic Repair System Products Liability Litigation in U.S. District Court for the Southern District of West Virginia.
The national law firm of Parker Waichman LLP has filed the lawsuit on behalf of the woman and continues to investigate claims by women who were injured by these and other defective transvaginal mesh devices.
This complaint alleges that the woman was fitted with the Prolift + M™ and the TVT Secur™ transvaginal mesh devices during a November 2009 surgery as a treatment for her stress urinary incontinence and pelvic organ prolapse. Like many other victims of the defects of transvaginal mesh, this woman began experiencing complications, namely severe and sometimes crippling pain that required her to undergo further medical treatments.
The attorneys at Parker Waichman believe the makers of these specific transvaginal mesh devices were aware of the dangers of them but continued to market them as safe and effective in the treatment of these two conditions that affect millions of women across the U.S. Specifically, the latest Parker Waichman complaint alleges that Ethicon and Johnson & Johnson were aware that “the mesh can react with the tissues of the body because the material used is not inert” but still failed to warn the public of these dangers.
Thousands of women were recipients of these devices and earlier this year, Ethicon indicated that it would no longer be selling either of the two devices that were implanted in the woman represented in this latest Parker Waichman lawsuit. The firm believes the company stopped marketing these products because “the devices are defective and present an unreasonable risk of harm” to the women that receive them.
Transvaginal mesh, in general, has come under increased scrutiny in the last two years, especially since many recipients of these devices began experiencing complications related to their defects, including severe pain, erosion of the devices through the skin or tissue, serious infections, and the need for constant revision surgeries to either correct or remove the devices.